Stock Under $10 with 50-100% upside potential - 14 Days FREE!

Healthcare Providers Increase Revenues, Avoid Penalties Through Covisint PQRS Program, A Stepping-Stone For ACO Success

Stock quotes in this article: CPWR 

DETROIT, Feb. 18, 2013 (GLOBE NEWSWIRE) -- Covisint, a Compuware (Nasdaq:CPWR) company, announced today that it has surpassed the $30 million mark in money returned to healthcare customers through the company's easy-to-use, PQRS solution. This achievement extends Covisint's position as one of the nation's PQRS submission leaders.

Compuware Logo
Covisint Logo

The March 8, 2013, PQRS submissions deadline is fast-approaching for the final opportunity to earn reimbursements in the last penalty-free year of this program. Covisint provides multiple reporting options, including a larger enterprise data-mining solution and, for individual providers or smaller practices, a web application that can take as little as 30 minutes to satisfy PQRS submission requirements.

As ACO and other shared savings programs expand, Covisint's PQRS submission program offers a speedy path to gain experience in ACO reporting due to the overlap in chronic disease and preventive care measures. Covisint has a 90 percent-plus PQRS customer retention rate.

Covisint lets providers use data captured during patient encounters, traditionally enabling them to earn an average of $1,000; practices can earn up to as much as $18,500 depending on their Medicare Part B Fee-for-Service allowed annual charges. This year, Covisint encourages providers to report for three key reasons:

1. to earn the 0.5 percent bonuses available from Centers for Medicare and Medicaid for 2012;

2. to gain the experience needed to successfully report in 2013--avoiding payment penalties of 1.5 percent on their 2015 fee schedule; and,

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,354.40 121.18 0.80%
NASDAQ 3,498.97 33.73 0.97%
S&P 500 1,667.47 17.00 1.03%
US 10 Yr 1.949% +0.084

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs